Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
Journal of Clinical Epidemiology
|
June 26, 2012
Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention
Sarah Dewilde, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 19, 2021
Evaluation of Triage Tests When Existing Test Capacity Is Constrained: Application to Rapid Diagnostic Testing in COVID-19
Janet Bouttell, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 31, 2017
Extrapolation of Survival Data in Cost-effectiveness Analyses: The Need for Causal Clarity
Neil Hawkins, Richard Grieve
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 16, 2010
Cost-effectiveness analysis: discount the placebo at your peril
Neil Hawkins, David A Scott
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 22, 2009
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis
Yogesh Suresh Punekar, Neil Hawkins
Health Economics
|
June 23, 2010
Reimbursement and value-based pricing: stratified cost-effectiveness analysis may not be the last word
Neil Hawkins, David A Scott
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2008
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies
Marco Barbieri, Neil Hawkins, Mark Sculpher
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 14, 2011
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment
Beth Woods, David Veenstra, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 15, 2005
Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response
Neil Hawkins, Mark Sculpher, David Epstein
Pharmacoeconomics - Open
|
July 2, 2025
Missing Pieces of the Puzzle to Address Market Failures for Antibiotics: Delinked Payment Systems and Insurance Value
Neil Hawkins, Adrian Towse, Amanda Adler
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
Journal of Clinical Epidemiology
|
June 26, 2012
Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention
Sarah Dewilde, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 19, 2021
Evaluation of Triage Tests When Existing Test Capacity Is Constrained: Application to Rapid Diagnostic Testing in COVID-19
Janet Bouttell, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 31, 2017
Extrapolation of Survival Data in Cost-effectiveness Analyses: The Need for Causal Clarity
Neil Hawkins, Richard Grieve
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 16, 2010
Cost-effectiveness analysis: discount the placebo at your peril
Neil Hawkins, David A Scott
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 22, 2009
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis
Yogesh Suresh Punekar, Neil Hawkins
Health Economics
|
June 23, 2010
Reimbursement and value-based pricing: stratified cost-effectiveness analysis may not be the last word
Neil Hawkins, David A Scott
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2008
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies
Marco Barbieri, Neil Hawkins, Mark Sculpher
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 14, 2011
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment
Beth Woods, David Veenstra, Neil Hawkins
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 15, 2005
Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response
Neil Hawkins, Mark Sculpher, David Epstein
Pharmacoeconomics - Open
|
July 2, 2025
Missing Pieces of the Puzzle to Address Market Failures for Antibiotics: Delinked Payment Systems and Insurance Value
Neil Hawkins, Adrian Towse, Amanda Adler
Page
of 11